medical research

Providence Business News Editor Mark Murphy joins Rhode Island Public Radio's Dave Fallon for our weekly business segment, The Bottom Line.

This week Dave and Mark are joined by Dr. Peter Snyder, Senior Vice President and Chief Research Officer at Lifespan. The three discuss the proposed New England Medical Innovation Center on the former I95 land. 

 

When to listen:

You can hear The Bottom Line each Friday at 5:50 p.m. on Rhode Island Public Radio, 88.1 FM, 91.5 FM and 102.7 FM.

Providence Business News Editor Mark Murphy joins Rhode Island Public Radio's Dave Fallon for our weekly business segment, The Bottom Line.

This week Dave and Mark are joined by Dr. Peter Snyder, Senior Vice President and Chief Research Officer at Lifespan. The three discuss the proposed New England Medical Innovation Center on the former I95 land. 

Your Weekly Briefing: Health In Rhode Island, 9/27

Sep 27, 2016
Kristin Gourlay / RIPR

Here’s what’s happening in health care in Rhode Island.

Wikimedia

The Rhode Island Foundation has seeded some of the state’s institutions of higher education with nearly half a million dollars in medical research funding. The money goes toward 20 research projects that range from studying heart failure in obese people to using mindfulness-based stress reduction techniques to help prevent pre-term births. 

RI Groups Join Call To Defund Planned Parenthood

Aug 21, 2015
Kristin Gourlay / RIPR

A group of Rhode Islanders plan to join a national day of protest Saturday morning against Planned Parenthood.  Rhode Island Right to Life and the Roman Catholic Diocese of Providence say they will be among those calling on lawmakers to stop public funding for the health care organization.

 The protests come after secretly filmed videos emerged last month of Planned Parenthood officials discussing the use of fetal tissue for medical research. Anti-abortion activists claim the group is using federal funding to illegally traffic body parts.

US Navy

Women and Infants Hospital is responding to allegations that a research study of premature babies in which it participated didn’t properly inform parents of the risks.